chemotherapy used for stage 1 breast cancer

Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf

Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf

Ngày tải lên : 15/02/2014, 04:20
... 2.03 0 .11 11 9.62 ജ50 y old 5 16 0. 31 1.00 3 .19 1. 12 11 .15 Deep vein thrombosis‡ 22 35 0.84 1. 34 1. 60 0. 91 2.86 ഛ49 y old 8 11 0.78 1. 08 1. 39 0. 51 3.99 ജ50 y old 14 24 0.88 1. 51 1. 71 0.85–3.58 *Seven ... 0.55 0.25 1. 15 Spine 31 23 1. 18 0.88 0.74 0. 41 1. 32 Radius, Colles’ 23 14 0.88 0.54 0. 61 0.29 1. 23 Other lower radius* 63 66 2. 41 2.54 1. 05 0.73 1. 51 Total 13 7† 11 1‡ 5.28 4.29 0. 81 0.63 1. 05 ഛ49 ... 23 3 10 .11 1. 43 0 .14 0.03–0.47 5-y predicted breast cancer risk, % ഛ2.00 35 13 5.54 2.06 0.37 0 .18 –0.72 2. 01 3.00 42 29 5 .18 3. 51 0.68 0. 41 1. 11 3. 01 5.00 43 27 5.88 3.88 0.66 0.39 1. 09 ജ5. 01 55...
  • 18
  • 645
  • 0
Suggested questions for stage 1

Suggested questions for stage 1

Ngày tải lên : 05/10/2013, 08:48
... interesting building in Guangzhou? Suggested topics in stage 2 & related questions for stage 3 Category 1: Describing things (1 test item) 1. Describing a piece of equipment you often use at ... Suggestedquestionsforstage 1 Warm-up 1. Could you show me your identification card please? 2. Could you tell me your full name ... popular? 9. What is the difference between fresh food and canned food? 10 . What can we do to solve the problem of food shortage? 11 . What are the advantages and disadvantages of family food? 2. Describing...
  • 10
  • 601
  • 0
Guidelines for management of breast cancer ppt

Guidelines for management of breast cancer ppt

Ngày tải lên : 28/03/2014, 23:20
... research tools. Stage grouping Stage 0: Tis, N0, M0 Stage I: T1, N0, M0 Stage IIa: T0, N1, M0 T1, N1, M0 T2, N0, M0 Stage IIb: T2, N1, M0 T3, N0, M0 Stage IIIa: T0, N2, M0 T1, N2, M0 T2, ... stage invasive breast cancer including surgery, adjuvant therapy for node- negative and node-positive breast cancer, primary chemotherapy in locally-advanced breast cancer, the definitions used ... of special problems in breast cancer 37 Figure 13 . Paget’s disease of the nipple-areola complex Figure 14 . Cancer of the male breast: diagnosis Diagnosis of breast cancer 15 Prognostic factors Several...
  • 57
  • 423
  • 0
Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt

Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt

Ngày tải lên : 18/06/2014, 16:20
... 1. 0 67.4 1. 0 1. 56 - 1. 75 14 8 56.4 1. 9 (1. 1, 3.6) 0.03 39.9 2 .1 (1. 2, 3.6) 0.008 > ;1. 75 90 25.0 3.5 (1. 9, 6.4) < 0.0 01 14.2 3.6 (2 .1, 6 .1) < 0.0 01 Age ≤ 55 years 78 82 .1 1.0 82 .1 1.0 >55 ... 2 .1 (1. 1, 3.7) 0. 01 1.7 (1. 1, 3.0) 0.047 Lymph node status Negative 1. 0 1. 0 Positive 3 .1 (1. 9, 5 .1) < 0.0 01 2.6 (1. 7, 4 .1) < 0.0 01 Estrogen-receptor status Positive 1. 0 1. 0 Negative 1. 6 ... 0.0 01 Age ≤ 55 years 1. 0 1. 0 >55 years 1. 8 (0.8, 4.2) 0 .14 2.7 (1. 2, 5.9) 0. 01 Size of tumour ≤ 2 cm 1. 0 1. 0 >2 cm 1. 0 (0.6, 1. 6) 0.96 1. 0 (0.7, 1. 6) 0.88 Grade of tumour 1 & 2 1. 0 1. 0 3...
  • 10
  • 490
  • 0
 Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"

Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"

Ngày tải lên : 31/10/2012, 16:57
... a potent PARP -1 inhibitor, AG143 61, on BRCA1 mutant and control cancer cells. (A) Clonogenic survival assay. Five hundred 780 (BRCA1 11 / 11 ), and 525 (BRCA1-/-), and NEU (BRCA1+/+) cells were ... human breast cancer cells using three PARP inhibitors: AG143 61, NU1025, and 3- aminobenzamide (3AB) [36]. We first tested a BRCA1 mutant ES cell line [BRCA1 trEx 11/ Δ 11 that carries one BRCA1 ... breast cancer cell lines: MCF-7 (BRCA1+/+), MDA-MB-2 31 (BRCA1+/-), HCC1937 (BRCA1-/-) and SUM1 315 MO2 (BRCA1-/-). Using both clonogenic survival assay and MTT assay, we found that PARP -1 inhibitors...
  • 7
  • 415
  • 0
Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc

Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc

Ngày tải lên : 14/02/2014, 21:20
... died from breast cancer was equal in both groups (13 5 /13 2,979 and 13 1 /13 3,085, respectively; RR 1. 03; 95% CI 0. 81- 1. 31) . Women who died of breast cancer were identified from a registry kept by ... MRI decrease breast cancer mortality among women age 40-49 years and 70 years and older? 11 Summary 11 Detailed Findings 12 Meta-analysis for women age 39-49 years 13 Results for women age ... collection for some of this work was supported by the NCI-funded Breast Cancer Surveillance Consortium (BCSC) cooperative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70 013 , U01CA69976,...
  • 95
  • 1K
  • 0
Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt

Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt

Ngày tải lên : 15/02/2014, 05:20
... out of 10 00 get breast cancer and die from it. The absolute reduction in breast cancer mortality was therefore only 0 .1% (1 out of 10 00) after 10 years in the Swedish trials. Screening for more ... for most of the observed breast cancer specifi c mortality reductions in Australian women since the national screening program began in 19 91. Breast Cancer Res Treat. Epub 2 011 Sep 29. 15 . ... treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ 2 011 ;343:d4692. 20. NHS cancer screening programmes. BASO Breast Audit 19 99/2000. www.cancerscreening.nhs.uk/breastscreen/publications.html...
  • 15
  • 528
  • 3
Tài liệu Báo cáo Y học: NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3 pptx

Tài liệu Báo cáo Y học: NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3 pptx

Ngày tải lên : 21/02/2014, 15:20
... 2.397 1. 983 1. 983 1. 983 3.368 3. 317 Asp9 – 4.779 2.747 2.558 Thr10 8. 914 4.445 4.297 1. 217 Arg 11 8. 510 4.504 1. 813 1. 678 1. 645 1. 645 3 .16 0 3 .16 0 Pro12 4.295 2.270 1. 990 1. 990 1. 879 3.705 3.5 91 CONH ... 4.347 2.389 1. 978 1. 978 1. 978 3.336 3.336 Asp9 4.666 2.707 2.543 Thr10 8.386 4.252 4 .15 5 1. 134 Arg 11 8.484 4.574 1. 798 1. 724 1. 629 1. 629 3 .16 0 3 .16 0 Pro12 4.327 2.255 1. 978 1. 978 1. 879 3.782 ... 7.788 CONHÂ 7. 017 NHCH 312 3456a6b GalNAc 7.803 1. 975 4.775 4. 016 3.850 3. 914 3.972 3. 715 3.6 91 1446 H. Mo ă ller et al. (Eur. J. Biochem. 269) Ó FEBS 2002 site of SM3 is shown in Fig. 5B. For comparison...
  • 12
  • 717
  • 0
Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer pptx

Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer pptx

Ngày tải lên : 05/03/2014, 12:20
... Coalition for Cancer Survivorship, Silver Spring, MD
  • 311
  • 1.3K
  • 0
BREAST CANCER - TREATMENT GUIDELINES FOR PATIENTS potx

BREAST CANCER - TREATMENT GUIDELINES FOR PATIENTS potx

Ngày tải lên : 06/03/2014, 01:20
... When chemotherapy is given after surgery for early stage breast cancer, it is called adjuvant chemotherapy. Sometimes chemo- therapy is given before surgery. This is called neoadjuvant chemotherapy. ... Bisphosphonates Bisphosphonates are used in breast cancer treatment to strengthen bones that have been weakened by invading breast cancer cells. The most commonly used bisphosphonates in breast cancer treatment ... doctors about your cancer stage and prognosis, and how they affect treatment options. System to Define Cancer Stage The system most often used to describe the extent of breast cancer is the TNM...
  • 92
  • 411
  • 0

Xem thêm